findmyKOL
Clinical trialNCT06238648RecruitingPhase 2Interventional

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

SponsorAcademic and Community Cancer Research UnitedEnrollment120Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-Cell LymphomaTransformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic in Rochester

    Rochester, Minnesota, United States

    Grzegorz S. Nowakowski
    Not, yet, recruiting
  • Siteman Cancer Center at Washington University

    St Louis, Missouri, United States

    Dilan A. Patel
    Not, yet, recruiting
  • Hackensack University Medical Center

    Hackensack, New Jersey, United States

    Lori Leslie
    Not, yet, recruiting
  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

    Miguel-Angel Perales
    Not, yet, recruiting
  • Unc Lineberger Comprehensive Cancer Center

    Chapel Hill, North Carolina, United States

    Natalie S. Grover
    Not, yet, recruiting
  • Huntsman Cancer Institute/university of Utah

    Salt Lake City, Utah, United States

    Allison Bock
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2024
Primary completion
31 Dec 2029
Completion
31 Dec 2030
Last update posted
26 Sept 2024
Registered enrollment
120
Registry id
NCT06238648
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.